Somewhat Negative Media Coverage Somewhat Unlikely to Impact Monsanto (MON) Share Price
News headlines about Monsanto (NYSE:MON) have been trending somewhat negative recently, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Monsanto earned a coverage optimism score of -0.01 on Accern’s scale. Accern also gave news stories about the basic materials company an impact score of 43.4256896772469 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the news stories that may have impacted Accern’s rankings:
- Bayer: Indian approval of Monsanto deal likely by April or May (smartbrief.com)
- Bayer expects CCI nod by Apr-May for $66 bn Monsanto deal (moneycontrol.com)
- Don’t let EPA and Monsanto hide the truth on Roundup (sacbee.com)
- Monsanto (MON) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- APD to Acquire Coal Gasification Technology from Shell (finance.yahoo.com)
Several brokerages have commented on MON. Barclays restated an “equal weight” rating and set a $124.00 target price (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Thursday, October 5th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a report on Tuesday. Macquarie downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Finally, Wells Fargo & Co raised their target price on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $126.40.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. During the same quarter last year, the business earned $0.21 earnings per share. Monsanto’s revenue for the quarter was up .3% on a year-over-year basis. sell-side analysts predict that Monsanto will post 5.76 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be issued a $0.54 dividend. The ex-dividend date is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. Monsanto’s dividend payout ratio (DPR) is presently 39.93%.
In other news, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now directly owns 56,743 shares in the company, valued at $6,772,277.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Somewhat Negative Media Coverage Somewhat Unlikely to Impact Monsanto (MON) Share Price” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://theolympiareport.com/2018/01/16/somewhat-negative-media-coverage-somewhat-unlikely-to-impact-monsanto-mon-share-price.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.